- Home
- TNYA vs NAUT Comparison
TNYA vs NAUT Comparison
Compare TNYA & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- NAUT
- Stock Information
- Founded
- TNYA 2016
- NAUT 2016
- Country
- TNYA United States
- NAUT United States
- Employees
- TNYA N/A
- NAUT N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- TNYA Health Care
- NAUT Industrials
- Exchange
- TNYA Nasdaq
- NAUT Nasdaq
- Market Cap
- TNYA 74.5M
- NAUT 86.4M
- IPO Year
- TNYA 2021
- NAUT N/A
- Fundamental
- Price
- TNYA $0.37
- NAUT $0.86
- Analyst Decision
- TNYA Strong Buy
- NAUT Hold
- Analyst Count
- TNYA 6
- NAUT 3
- Target Price
- TNYA $8.60
- NAUT $3.58
- AVG Volume (30 Days)
- TNYA 2.1M
- NAUT 209.5K
- Earning Date
- TNYA 05-07-2025
- NAUT 04-29-2025
- Dividend Yield
- TNYA N/A
- NAUT N/A
- EPS Growth
- TNYA N/A
- NAUT N/A
- EPS
- TNYA N/A
- NAUT N/A
- Revenue
- TNYA N/A
- NAUT N/A
- Revenue This Year
- TNYA N/A
- NAUT N/A
- Revenue Next Year
- TNYA N/A
- NAUT N/A
- P/E Ratio
- TNYA N/A
- NAUT N/A
- Revenue Growth
- TNYA N/A
- NAUT N/A
- 52 Week Low
- TNYA $0.39
- NAUT $0.66
- 52 Week High
- TNYA $4.78
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- TNYA 29.46
- NAUT 58.88
- Support Level
- TNYA $0.36
- NAUT $0.66
- Resistance Level
- TNYA $0.53
- NAUT $1.01
- Average True Range (ATR)
- TNYA 0.04
- NAUT 0.06
- MACD
- TNYA -0.00
- NAUT 0.04
- Stochastic Oscillator
- TNYA 3.86
- NAUT 65.77
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.